Form 4 for VTGN Vistagen Therapeutics, Inc.
Accepted 2025-01-13 00:00:00 ET · period of report 2024-12-31 · accession 0001415889-25-001396 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-13 | 2024-12-31 | VTGN | Anderson Cynthia Lynn | CFO | A - Grant | $2.51 | +2,592 | 6,184 | +72% | +$6,506 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-31 | A | A | 2,592 | $2.51 | 6,184 | D | — | — |